Is Coronavirus the Spark That Telehealth Needs?

Posted by Victoria Summers on Fri, Mar 13, 2020

Earlier this year, experts agreed that telehealth was poised to become mainstream in 2020. Spurred by broad access through smartphones and supported by health plans across the U.S., telehealth finally has the financial reimbursement and regulatory guidelines to enable patients and physicians to connect online. But now, COVID-19 has come on the scene. With the outbreak of the coronavirus in China and its rapid spread around the world, private companies and governments have encouraged people to quarantine themselves if they believe that they may have the virus. But how do patients know if they have it? If they suspect that they do have it, how can they access care in a way that doesn’t expose others? And if patients have health questions unrelated to coronavirus, wouldn’t they prefer to stay away from clinics and hospitals to decrease their risk of exposure?


>
Read More

Structured Assessment of Value Strategy is Key to Effective IDN Partnerships

Posted by Matt Ruple on Thu, Sep 19, 2019

Joe Stevens co-wrote this blog post with Matt Ruple. 

Our life sciences clients often ask, “How can we create mutual value for large, organized customers and ourselves?” While this sounds like a simple question, it masks a number of challenges. In previous posts we discussed how IDNs try to create mutual value, but ultimately elevate one key management goal as their top organizational priority. Frequently, these management goals transform from ideas to action at the service line level, where various departments within an IDN then express therapeutic area level needs. For example, a large IDN taking capitated payments for some of its population may track total cost of care across specialty drugs in oncology and rheumatology, while in cardiology, the focus may be on transition of care and discharge protocols to reduce readmissions.


>
Read More

How Gamification Can Help Pharma Companies Play to Win

Posted by Rachael Pius on Fri, Mar 29, 2019

Maurice Solomon, Victoria Summers and Melissa Visintin co-wrote this article with Rachael Pius.

Whether we like to admit it or not, many of us know the unique rush that comes from swiping a series of multicolored jelly beans in Candy Crush. We’ve experienced the thrill of landing a triple word score in Words With Friends, and we’ve known the satisfaction that comes from—of all things—successfully harvesting a field of wheat in Farmville. Gaming is a universal pursuit, triggering not only our competitive instincts but also our desires for achievement and recognition. And with the rise of app- and social-media-based games, there are more people playing than ever before: The number of online gamers is expected to reach 2.7 billion by 2021, according to gaming analytics firm NewZoo.


>
Read More

Walking the Walk: How Pharma Companies Can Deliver Patient-Centric Experiences

Posted by Hensley Evans on Thu, Jul 12, 2018

The pharmaceutical industry has been talking about patient centricity for a long time, but despite having been a topic of great interest for more than a decade, there remains a lot of uncertainty about what being a truly patient-centric organization means. What does it mean to walk the walk and, more importantly, how can organizations ensure that a focus on patient centricity not only benefits patients but also drives business success?


>
Read More

How Understanding Unconscious Biases Can Improve Pharma Marketing

Posted by Fiona Taylor on Thu, Mar 01, 2018

Every day, our brains outsource hundreds of decisions to our subconscious, which uses mental shortcuts to get us to an answer fast. Understanding these shortcuts and the biases that we may fall prey to can shed light on all sorts of decisions we make, from the car we drive to where we live to how we choose our healthcare treatments.


>
Read More